Eradivir $10M Trigger: Dial Your Next Deal

🚀 Battle Card: Eradivir

• Martin Low, CEO 📧 <martin.low@eradivir.com>

• A $10M financing supercharges Phase 2 challenge trials of EV25 and advances EV148 RSV development → Source

• Meeting aggressive Phase 2 trial milestones

• Securing follow-on funding for pipeline expansion

• Primary: eClinical trial management software → Accelerate trial workflows and data accuracy

• Expansion: AI-driven patient recruitment tool → Reduce enrollment time

• HQ: West Lafayette, IN

• Employees: ≈ 50

• Rev: ≈ $2 M

• Website: [eradivir.com](https://eradivir.com/)

🤼 Competitive Intel

• Medidata — eClinical / CTMS
• Unique edge: Global trial data integration
• Evaluated by VP Ops for workflow centralization

• Veeva — eClinical / CTMS
• Unique edge: Unified clinical cloud
• Evaluated by IT & CTO for system interoperability

• Oracle Health Sciences — eClinical / CTMS
• Unique edge: Robust analytics and scalability
• Evaluated by CFO for total cost of ownership

• Medrio — eClinical / CTMS
• Unique edge: Lightweight, modular design
• Evaluated by Clinical Ops for rapid deployment

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑≈ TBD❑
OFFER_BRIEF   = ❑eClinical trial management software❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Martin
COMPANY     = Eradivir
DEPT        = Clinical Operations
SIZE        = ≈ 50
BOTTLENECK  = Meeting aggressive Phase 2 trial milestones
EVENT       = Raises $10M
DETAIL      = closing of a $10M private financing round
PAIN        = Meeting aggressive Phase 2 trial milestones
SRC         = https://vcnewsdaily.com/eradivir/venture-capital-funding/tbctplhxzc
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 50
REV_EST     = ≈ $2 M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ 50-person Clinical Operations

Martin—noticed your Clinical Operations team is ≈ 50.

That’s when Meeting aggressive Phase 2 trial milestones slows growth.

We helped ≈ TBD fix this with eClinical trial management software.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ TBD.

DM ≤45 words, TONE:
Saw your post about closing of a $10M private financing round — Meeting aggressive Phase 2 trial milestones.  
eClinical trial management software. ≈ TBD.  
Quick chat?